MICHAEL CHRISTENSEN: Open Payments
NPI 1790330454 · SOUTH JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 19 payments from 10 companies in 2025. Trend: 2023 $239 · 2024 $299 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $94 |
| ABBVIE INC. | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $74 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
Products named: INGREZZA, VRAYLAR, AUSTEDO XR, Auvelity, TRINTELLIX, INSPIRE, REXULTI, INVEGA SUSTENNA.
Industry payments across UT — which companies pay providers there.
